p32/OPA1 axis-mediated mitochondrial dynamics contributes to cisplatin resistance in non-small cell lung cancer

Metformin-induced AMPK activation promotes cisplatin resistance through PINK1/Parkin dependent mitophagy in gastric cancer

(2022) Yi-Yi Xiao et al.   Frontiers in Oncology

Role of C1QBP/p32 and its therapeutic potential in breast carcinoma and other cancers

(2021) Ken Matsumoto et al.   CURRENT MEDICINAL CHEMISTRY

Overexpression of Multifunctional Protein p32 Promotes a Malignant Phenotype in Colorectal Cancer Cells

(2021) Carlos Alejandro Egusquiza-Alvarez et al.   Frontiers in Oncology

High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy

(2021) Marco Fiorillo et al.   Frontiers in Oncology

MiR-29b-3p Reverses Cisplatin Resistance by Targeting COL1A1 in Non-Small-Cell Lung Cancer A549/DDP Cells

(2020) Rui Jia et al.   Cancer Management and Research

p32/C1QBP regulates OMA1-dependent proteolytic processing of OPA1 to maintain mitochondrial connectivity related to mitochondrial dysfunction and apoptosis

(2020) Solhee Noh et al.   Scientific Reports

Globular C1q Receptor (gC1qR/p32/HABP1) Suppresses the Tumor-Inhibiting Role of C1q and Promotes Tumor Proliferation in 1q21-Amplified Multiple Myeloma

(2020) Jiadai Xu et al.   Frontiers in Immunology

Mitochondrial Fusion: The Machineries In and Out

(2020) Song Gao et al.   TRENDS IN CELL BIOLOGY

LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway

(2020) Li Xu et al.   BMC Pulmonary Medicine

Metformin use and lung cancer survival: a population-based study in Norway

(2020) Suzan Brancher et al.   BRITISH JOURNAL OF CANCER

α-Hederin inhibits the growth of lung cancer A549 cells in vitro and in vivo by decreasing SIRT6 dependent glycolysis

(2020) Cong Fang et al.   PHARMACEUTICAL BIOLOGY

Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers

(2019) Subbroto Saha et al.   Journal of Clinical Medicine

Metformin‐sensitized NSCLC cells to osimertinib via AMPK‐dependent autophagy inhibition

(2019) Hengyi Chen et al.   Clinical Respiratory Journal

Tracking intra‐ and inter‐organelle signaling of mitochondria

(2019) Corina T. Madreiter‐Sokolowski et al.   FEBS Journal

Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells

(2019) Markus Kleih et al.   Cell Death & Disease

Metformin for lung cancer prevention and improved survival

(2018) Juliana F. Roos et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis

(2018) Huijuan Xiao et al.   Cell and Bioscience

LATS2 promotes apoptosis in non-small cell lung cancer A549 cells via triggering Mff-dependent mitochondrial fission and activating the JNK signaling pathway

(2018) Yudong Xie et al.   BIOMEDICINE & PHARMACOTHERAPY

Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1

(2017) Gerhard Hamilton et al.   Expert Opinion on Drug Metabolism & Toxicology

Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells

(2017) Xiao-Jian Han et al.   ONCOLOGY REPORTS

Mitochondrial Dynamics and Metabolic Regulation

(2016) Timothy Wai et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Mitochondrial dynamics regulating chemoresistance in gynecological cancers

(2015) Bao Kong et al.   Annals of the New York Academy of Sciences

Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation

(2015) Yong-Min Choi et al.   PLoS One

p32 protein levels are integral to mitochondrial and endoplasmic reticulum morphology, cell metabolism and survival

(2013) MengJie Hu et al.   BIOCHEMICAL JOURNAL

Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells

(2013) Yuan Gao et al.   CANCER LETTERS

Intracellular ATP-Binding Cassette Transporter A3 is Expressed in Lung Cancer Cells and Modulates Susceptibility to Cisplatin and Paclitaxel

(2013) Tobias R. Overbeck et al.   ONCOLOGY

Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage

(2012) C. Algire et al.   Cancer Prevention Research

Mitochondrial fusion: A mechanism of cisplatin-induced resistance in neuroblastoma cells?

(2012) Giada Santin et al.   NEUROTOXICOLOGY

p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding ability

(2012) Mikako Yagi et al.   NUCLEIC ACIDS RESEARCH

Fusion and Fission: Interlinked Processes Critical for Mitochondrial Health

(2011) David C. Chan   Annual Review of Genetics

Overexpression of optic atrophy 1 protein increases cisplatin resistance via inactivation of caspase-dependent apoptosis in lung adenocarcinoma cells

(2011) Hsin-Yuan Fang et al.   HUMAN PATHOLOGY

p32 regulates mitochondrial morphology and dynamics through parkin

(2011) Y. Li et al.   NEUROSCIENCE

Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy

(2010) Rie Amamoto et al.   CANCER SCIENCE